As a gene that is critical for cell growth and regulation of lipid homeostasis and has been shown to be responsive to changes in the nutritional environment, Pcyt2 should be considered when developing novel approaches in the treatment of metabolic disorders and cancer. This evidence concerns the gene PCYT2 and metabolic disease.